Clinopathologic Conference, Celiac Disease
NEJM 374:1875-1883, Case 14-2016, 2016
Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025
NSAIDS, Hormonal Contraception, and Venous Thromboembolism, A Harmful Drug Interaction That Deserves More Attention
BMJ 382:p1990, Schmidt,M., 2023
Vaccine-Induced Thrombocytopenia with Severe Headache
NEJM 385:doi:10.1056/NEJMc2112974, Salih, F.,et al, 2021
Drug-Related Demyelinating Syndromes: Understanding Risk Factors, Pathophysiological Mechanisms and Magnetic Resonance Imaging Findings
Mult Scler Rel Dis 55:103146, Rimkus, C.M.,et al, 2021
HIV-Associated CD8 Encephalitis: A UK Case Series and Review of Histopathologically Confirmed Cases
Front Neurol 12:628296, Lucas,S.B.,et al, 2021
Epilepsy in Older People
Lancet 395:735-748, Sen, A.,et al, 2020
Acute Encephalitis in Immunocompetent Adults
Lancet 393:702-716, Venkatesan, A.,et al, 2019
Natalizumab-Associated PML
Neurol 88:1197-1205, Schwab, N.,et al, 2017
Diagnosis and Management of Acute Cerebellar Infarction
Stroke 45:e56-e58, Wright, J.,et al, 2014
The Spectrum of Statin Myopathy
Curr Opin Rheumatol 25:747-752, Mohassel, P. & Mammen, A.L., 2013
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
NEJM 366:1870-1880,1938, Bloomgren, G.,et al, 2012
Use of Ibuprofen and Risk of Parkinson Disease
Neurol 76:863-869, Gao,X.,et al, 2011
Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011
Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study
BMJ 343:d3450, Schmidt, M.,et al, 2011
Risk Development of Medication Overuse Headache With Nonsteroidal Anti-inflammatory Drug Therapy for Migraine A Critically Appraised Topic
The Neurologist 17:297-299, Starling, A.J.,et al, 2011
Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients
Medicine 89:166-175, Mu�oz,P., et al, 2010
Hyperthyroidism and Risk of Ischemic Stroke in Young Adults: A 5-Year Follow-Up Study
Stroke 41:961-966, Sheu,J.-J., et al, 2010
Progressive Multifocal Leukoencephalopathy: Can We Reduce Risk in Patients Receiving Biological Immunomodulatory Therapies?
Ann Neurol 68:271-274, Tyler,K., 2010
Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009
Risk of Dementia and AD with Prior Exposure to NSAIDs in an Elderly Community-Based Cohort
Neurol 72:1899-1905,1884, Breitner,J.C.S.,et al, 2009
NSAID Use and Dementia Risk in the Cardiovascular Health Study: Role of APOE and NSAID Type
Neurol 70:17-24, Szekely,C.A.,et al, 2008
Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Hemorrhagic Stroke Risk: The Acute Brain Bleeding Analysis Study
Stroke 39:845-849, Choi,N.-K.,et al, 2008
Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008
Progressive Multifocal Leukoencephalopathy After Rituximab in a Case of Non-Hodgkin Lymphoma
Neurol 69:704-706, Kranick,S.M.,et al, 2007
Chronic Daily Headache
NEJM 354:158-165, Dodick,D.W., 2006
Progressive Multifocal Leukoencephalopathy Revisited: Has the Disease Outgrown Its Name?
Ann Neurol 60:162-173, Koralnik,I.J., 2006
Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005
Infliximab and Reactivation of Cerebral Toxoplasmosis
NEJM 353:1530-1531, Callegari,P.E., 2005
Intracerebral Hemorrhage
The Neurologist 11:311-324, Badjatia,N. &Rosand,J., 2005
Recent Developments in Thyroid Eye Disease
BMJ 329:385-390, Cawood,T.,et al, 2004
Risk of Stroke Associated With Nonsteroidal Anti-Inflammatory Drugs
Stroke 34:379-386, Bak,S.,et al, 2003
Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hospitalization for Intracerebral Hemorrhage
Stroke 34:387-391, Johnsen,S.P.,et al, 2003
Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease
Arch Neurol 60:1059-1064,1043, Chen,H.,et al, 2003
Risk Factors for Cerebral edema in Children With Diabetic Ketoacidosis
NEJM 344:264-269,302, Glaser,N.,et al, 2001
Early Clinical and Radiological Predictors of Fatal Brain Swelling in Ischemic Stroke
Stroke 30:287-292, Krieger,D.W.,et al, 1999
Risk of Primary Intracerebral Haemorrhage Associated with Aspirin and Non-Steroidal Anti-Inflammatory Drugs:Case-Control Study
BMJ 318:759-764, Thrift,A.G.,et al, 1999
Concurrent Medical Disease in Work-Relatede Carpal Tunnel Syndrome
Arch Int Med 158:1506-1512, 14961998., Atcheson,S.G.,et al, 1998
Nonaccidental Head Injury in Infants-The"Shaken-Baby Syndrome"
NEJM 338:1822-1829, Duhaime,A-C.,et al, 1998
Risk of Alzheimer's Disease and Duration of NSAID Use
Neurol 48:626-632, Stewart,W.F.,et al, 1997
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
NEJM 336:973-979, 1014-10161997., Ridker,P.M.,et al, 1997
The Relation of Transient Hypothyroxinemia in Preterm Infants to Neurologic Development at Two Years of Age
NEJM 334:821-827, 8571996., Reuss,M.L.,et al, 1996
Do Nonsteroidal Anti-Inflammatory Drugs Decrease Risk for Alzheimer's Disease, Rotterdam Study
Neurol 45:1441-1445, Andersen,K.,et al, 1995